Systemic bevacizumab for treatment of recurrent respiratory papillomatosis
Author:
Funder
Science and Technology Commission of Shanghai Municipality
Shanghai Municipal Key Clinical Specialty
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s00405-023-08430-x.pdf
Reference27 articles.
1. Hoesli RC, Wingo ML, Richardson BE, Bastian RW (2020) Identification of 11 different HPV subtypes in adult patients with recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 163(4):785–790. https://doi.org/10.1177/0194599820931817
2. Benedict JJ, Derkay CS (2021) Recurrent respiratory papillomatosis: A 2020 perspective. Laryngosc Investig Otolaryngol 6(2):340–345. https://doi.org/10.1002/lio2.545
3. Donne AJ, Kinshuck A (2021) Pharmacotherapy for recurrent respiratory papillomatosis (RRP): a treatment update. Expert Opin Pharmacother 22(14):1901–1908. https://doi.org/10.1080/14656566.2021.1935870
4. Zeitels SM, Lopez-Guerra G, Burns JA, Lutch M, Friedman AM, Hillman RE (2009) Microlaryngoscopic and office-based injection of bevacizumab (Avastin) to enhance 532-nm pulsed KTP laser treatment of glottal papillomatosis. Ann Otol Rhinol Laryngol Suppl 201:1–13. https://doi.org/10.1177/000348940911800901
5. Nagel S, Busch C, Blankenburg T, Schütte W (2009) Behandlung der respiratorischen Papillomatose-Kasuistik zur systemischen Therapie mit Bevacizumab [Treatment of respiratory papillomatosis—a case report on systemic treatment with bevacizumab]. Pneumologie 63(7):387–389. https://doi.org/10.1055/s-0029-1214714
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effectiveness of surgery combined with photodynamic therapy for recurrent respiratory papillomatosis;American Journal of Otolaryngology;2024-11
2. Quantifying Bevacizumab Efficacy in Recurrent Respiratory Papillomatosis;The Laryngoscope;2024-08-29
3. A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis;The Laryngoscope;2024-08-03
4. Global trends and hotspots on recurrent respiratory papillomatosis: A 20‐year bibliometric analysis;Laryngoscope Investigative Otolaryngology;2024-06
5. Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis;Journal of Voice;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3